Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 32 | 38 | +6 |
| Shares | 18.8M | 18.7M | −127.2K (−0.7%) |
| Value | $12.2M | $9.99M | −$2.18M (−17.9%) |
New holders (11)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pfizer Inc | 626,109 | $335.0K | 0.01% |
| Citadel Advisors LLC | 78,961 | $42.3K | 0.00% |
| Engineers Gate Manager LP | 72,402 | $38.7K | 0.00% |
| Goldman Sachs Group Inc | 50,020 | $26.8K | 0.00% |
| Velan Capital Investment Management LP | 50,000 | $26.8K | 0.02% |
| Squarepoint Ops LLC | 48,971 | $26.2K | 0.00% |
| Millennium Management LLC | 47,025 | $25.2K | 0.00% |
| XTX Topco Ltd | 44,891 | $24.0K | 0.00% |
| Virtu Financial LLC | 29,552 | $16.0K | 0.00% |
| SBI Securities Co., Ltd. | 200 | $107 | 0.00% |
| BNP Paribas Arbitrage, SA | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 500,000 | $324.0K |
| Newtyn Management, LLC | 468,910 | $303.9K |
| Susquehanna International Group, LLP | 147,926 | $95.9K |
| Prudential Financial Inc | 59,200 | $38.4K |
| Two Sigma Securities, LLC | 25,509 | $16.5K |